Mesa Laboratories
MLAB
172 hedge funds and large institutions have $1.44B invested in Mesa Laboratories in 2021 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 66 increasing their positions, 46 reducing their positions, and 14 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
93% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 14
43% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 46
13% more capital invested
Capital invested by funds: $1.28B → $1.44B (+$164M)
8% more funds holding
Funds holding: 159 → 172 (+13)
0.07% more ownership
Funds ownership: 91.59% → 91.66% (+0.07%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Principal Financial Group
Des Moines,
Iowa
|
+$11.4M |
| 2 |
RIM
Ranger Investment Management
Dallas,
Texas
|
+$6.82M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$5.91M |
| 4 |
Goldman Sachs
New York
|
+$3.87M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
+$3.68M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$22.3M |
| 2 |
BlackRock
New York
|
-$13.8M |
| 3 |
Two Sigma Investments
New York
|
-$3.05M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$2.72M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$1.63M |
MLAB Hedge Fund Activity: Q3 2021 in Review
172 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Mesa Laboratories (MLAB) for Q3 2021, worth a combined $1.44B — up 13% from $1.28B a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new MLAB positions and 14 closed out — a net gain of 13 holders — while 66 added to existing stakes and 46 trimmed.
The largest buyer was Principal Financial Group, adding an estimated $11.4M. The largest seller was T. Rowe Price Associates, cutting an estimated $22.3M.
- 172 institutional investors held Mesa Laboratories (MLAB) as of Q3 2021, up from 159 in Q2 2021.
- Funds reported $1.44B of Mesa Laboratories stock for Q3 2021, up 13% quarter-over-quarter.
- 27 funds opened new Mesa Laboratories positions in Q3 2021 and 14 closed out, a net change of +13 holders.
- The largest Mesa Laboratories buyer in Q3 2021 was Principal Financial Group, an estimated $11.4M added.
- The largest Mesa Laboratories seller in Q3 2021 was T. Rowe Price Associates, an estimated $22.3M sold.
Based on aggregated 13F filings for Q3 2021.